Details for New Drug Application (NDA): 202019
✉ Email this page to a colleague
NDA 202019 describes VARENICLINE TARTRATE, which is a drug marketed by Ajanta Pharma Ltd, Alkem Labs Ltd, Apotex, Aurobindo Pharma, Dr Reddys, Hetero Labs Ltd Iii, Kanchan Hlthcare, Lupin Ltd, Macleods Pharms Ltd, Mankind Pharma, Micro Labs, Ne Rx Pharma, Ph Health, Pharmobedient, Piramal, Regcon Holdings, Rhodes Pharms, Shilpa, Umedica, Viwit Pharm, and Zydus, and is included in twenty-one NDAs. It is available from twenty-eight suppliers. Additional details are available on the VARENICLINE TARTRATE profile page.
The generic ingredient in VARENICLINE TARTRATE is varenicline tartrate. There are twelve drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the varenicline tartrate profile page.
The generic ingredient in VARENICLINE TARTRATE is varenicline tartrate. There are twelve drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the varenicline tartrate profile page.
Summary for 202019
| Tradename: | VARENICLINE TARTRATE |
| Applicant: | Pharmobedient |
| Ingredient: | varenicline tartrate |
| Patents: | 0 |
Pharmacology for NDA: 202019
| Mechanism of Action | Cholinergic Agonists Partial Cholinergic Nicotinic Agonists |
Medical Subject Heading (MeSH) Categories for 202019
Suppliers and Packaging for NDA: 202019
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 202019 | ANDA | Mylan Pharmaceuticals Inc. | 0378-5089 | 0378-5089-73 | 56 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5089-73) |
| VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 202019 | ANDA | Mylan Pharmaceuticals Inc. | 0378-5090 | 0378-5090-73 | 56 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5090-73) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 0.5MG BASE | ||||
| Approval Date: | Feb 28, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
| Approval Date: | Feb 28, 2024 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
